E-pharma startups seek more clarity on data privacy

New Delhi: E-pharmacy players on Tuesday said they support the government’s draft e-Pharmacy policy but look forward to more clarity on the data privacy and data management.

Digital health platforms said they are in total support of the draft rules, as it would bring affordability and transparency for consumers, and would oppose the nation-wide strike called by the All India Organisation of Chemists and Druggists (AIOCD) on September 28, 2018.

“Few areas we would like additional clarity on

would be data privacy and data management,” said Prashant Tandon, co-founder, 1mg, on being asked about problems faced by the sector.

The online pharma players were speaking at a media briefing here.

Tandon further said: “There is a parallel Sri Krishna Committee for digital data, which is going on… We would prefer a clarity whether we have to comply with it.

Talking of the recent opposition to the government’s draft policy, the stakeholders said e-pharmacies would empower consumers and provide them multiple options to help them make an informed choice while buying their medicines.

  • Related Posts

    Diabetic drug metformin found to act on brain

    NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

    Hetero debuts semaglutide generic in emerging markets

    New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Diabetic drug metformin found to act on brain

    Diabetic drug metformin found to act on brain

    Hetero debuts semaglutide generic in emerging markets

    Hetero debuts semaglutide generic in emerging markets

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework